I want to thank all for creating the foundation and website. 9 years ago when I was diagnosed there was little information available. I had to do a lot of research on my own. The work you are doing is awesome! No one should ever die from anal cancer.

Maria

Since the Foundation’s inception in 2010 we have dedicated ourselves to improving the lives of anal cancer thrivers, supporting and funding research for anal cancer as well as HPV-related cancers, creating a collaborative space for clinicians to share knowledge and ideas, and moving the pendulum forward in increasing vaccination rates for girls and boys. We continue to work with leaders in the field to not only eradicate HPV-related cancers for future generations, but to eliminate research and scientific silos and bring improved and novel treatments to those diagnosed with anal cancer.

Our staff and boards work every day to improve the once bleak landscape facing the anal cancer community. It is our promise and commitment that tomorrow will  be different for our community!

The difference your 2015 contribution made

ONE TREATMENT, MANY CURES

ONE TREATMENT, MANY CURES

$1.2 MILLION HPV-RELATED CANCER GRANT

We continued our multi-year initiative for novel HPV-related immunotherapy research at Dana-Farber Cancer Institute. This initiative is looking for new treatments for advanced staged HPV-related anal, cervical and oropharyngeal cancers and is led by Dr. Ellis Reinherz and Dr. Robert Haddad. This study is co-supported by Stand Up To Cancer and the Farrah Fawcett Foundation.

PREVENTION FOR GIRLS AND BOYS

PREVENTION FOR GIRLS AND BOYS

HPVACTION: GIVE BOYS THE VACCINE!

Our HPV Action (HPVA) coalition continues to grow in the UK as HPV vaccination for boys remains an important public health priority. This autumn, HPVA launched its new case for gender-neutral HPV vaccination: 'Jabs for the Boys.' HPVA’s statement of support for gender neutral vaccination has gained tremendous support by over 100 experts in the field including Nobel Prize winner Harald zur Hausen, who discovered the link between HPV and cervical cancer.

REDEFINING TREATMENT

REDEFINING TREATMENT

SUPPORTING RESEARCH AT MD ANDERSON

The treatment for anal cancer has barely changed in 40 years. Immunotherapy is an emerging field of cancer treatment, in which the body’s immune system is harnessed to fight cancer cells. With the help of our donors, we supported groundbreaking anal cancer treatment research at MD Anderson Cancer Center. This immunotherapy clinical trial, led by Dr. Cathy Eng, is the first of its kind for metastatic anal cancer, and seeks to find new treatment options. The number of scientific studies funded by the Foundation seeking a cure continues to grow thanks to your help.

CONNECTING THE COMMUNITY

CONNECTING THE COMMUNITY

PEER TO PEER SUPPORT PROGRAM AND ONLINE EDUCATIONAL FORUMS

We continue to lead by providing resources to patients they can’t find elsewhere. The anal cancer community had an unprecedented year with the first of our online event series titled “Taking Care of You” for anal cancer thrivers with over 120 participants during the live broadcast. Anal cancer thrivers can view a recording of the event, which featured experts and thrivers discussing side effect management. With our educational forums, and more than 150 participants in our Peer to Peer Support Program, the anal cancer community has more resources available to them than ever before. Stay tuned to our YouTube channel and Google+ page for upcoming events!

LEADING THE CHARGE

LEADING THE CHARGE

SYMPOSIUM ON KEY ISSUES IN HPV PREVENTION AND EARLY DIAGNOSIS

Collaboration is key to achieving our goals and furthering our mission. In April, we co-sponsored the European Men’s Health Forum Symposium “Key Issues in HPV Prevention and Early Diagnosis.” We organized a community panel for this year’s International Anal Neoplasia Society conference where clinicians heard from thrivers about their experiences. The Foundation has also held strategy meetings with local and national health agencies to improve vaccine uptake among all children. Finally, our Peer to Peer Support Program has been recognized as a leader in the field of cancer care: we recently presented on our innovative program evaluation and database management at the Volunteer Management in Cancer Care symposium.

ENDING HPV: RACING TO SAVE LIVES

ENDING HPV: RACING TO SAVE LIVES

NOMAN IS AN ISLAND: RACE TO END HPV AND PREVENT 5% OF CANCERS

A record number of participants joined our campaign to raise awareness that HPV causes 5% of all cancers using the medium of extreme endurance events this summer. On land, our cyclists triumphed in the Trois Etapes Giro and Trois Etapes Tour, while our rowing teams battled the Mediterranean, racing from Barcelona to Ibiza and back. Coverage for the campaign included Bloomberg, BBC News London, City AM and Yahoo Travel. For more information on NOMAN and to participate in the campaign, please visit NOMANcampaign.org.